Yan-Xing Han Selected Research

Yan-Xing Han Research Topics

6	Colorectal Neoplasms (Colorectal Cancer) 07/2020 - 01/2016
6	Neoplasms (Cancer) 07/2020 - 07/2013
3	Infections 03/2011 - 12/2005
2	Rectal Neoplasms (Rectal Cancer) 02/2016 - 01/2016
2	Hepatitis B 03/2011 - 12/2005
1	Glioma (Gliomas) 01/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Inflammation (Inflammations) 01/2017
1	Hepatitis 03/2011
1	Chronic Hepatitis B 03/2011
1	Hepatitis C 09/2010

5	RNA (Ribonucleic Acid)IBA 07/2020 - 09/2010
3	Messenger RNA (mRNA)IBA 01/2019 - 04/2017
3	LipidsIBA 10/2017 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 11/2017 - 04/2017
2	Hyaluronic Acid (Hyaluronan)IBA 11/2017 - 10/2017
2	Fluorouracil (Carac)FDA LinkGeneric 02/2016 - 01/2016
2	Hepatitis B e AntigensIBA 03/2011 - 12/2005
2	DNA (Deoxyribonucleic Acid)IBA 03/2011 - 12/2005
1	Biocompatible Materials (Biomaterials)IBA 07/2020
1	Chlorogenic AcidIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	BerberineIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Temozolomide (Temodar)FDA LinkGeneric 01/2019
1	3' Untranslated Regions (3' UTR)IBA 01/2019
1	CytokinesIBA 01/2017
1	Therapeutic UsesIBA 02/2016
1	squaric acidIBA 07/2013
1	fosbretabulin (combretastatin A4)IBA 07/2013
1	Lamivudine (Epivir)FDA Link 03/2011
1	Pharmaceutical PreparationsIBA 03/2011
1	oxymatrineIBA 03/2011
1	HSC70 Heat-Shock ProteinsIBA 09/2010
1	4- (2- (4- methoxybenzyl)perhydropyrido(3,2,1- ij)(1,6)naphthyridin- 1- yl)butanoic acidIBA 09/2010
1	Foscarnet FDA LinkGeneric 12/2005
1	Antiviral Agents (Antivirals)IBA 12/2005